AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WOLVERINE TRADING, LLC | 14,600 | $13,511 | 0.00% |
| WOLVERINE TRADING, LLC | 20,198 | $18,691 | 0.00% |
| BlackRock Inc. | 2,736,856 | $2,504,224 | 0.00% |
| Bank of New York Mellon Corp | 71,836 | $65,730 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 14,000 | $12,810 | 0.00% |
| AdvisorNet Financial, Inc | 5,000 | $4,575 | 0.00% |
| Citadel Advisors | 109,400 | $100,101 | 0.00% |
| Citadel Advisors | 37,900 | $34,679 | 0.00% |
| Citadel Advisors | 965 | $883 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 122,500 | $112,700 | 0.00% |
| Tower Research Capital LLC (TRC) | 9,869 | $9,030 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 325,132 | $297,496 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 25,285 | $23,136 | 0.00% |
| HighTower Advisors, LLC | 70,350 | $65,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 170,349 | $155,869 | 0.00% |
| PrairieView Partners, LLC | 4,000 | $3 | 0.00% |
| Truvestments Capital LLC | 756 | $692 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 60,300 | $55,476 | 0.00% |
| Hexagon Capital Partners LLC | 186 | $170 | 0.00% |
| JPMORGAN CHASE & CO | 37,903 | $34,681 | 0.00% |
External links
This page lists AKEBIA THERAPEUTICS INC's shareholders in Q2 2023. To view AKEBIA THERAPEUTICS INC's shareholder history, click here.